Proteomic Protease Substrate Profiling of tPA Treatment in Acute Ischemic Stroke Patients: A Step Toward Individualizing Thrombolytic Therapy at the Bedside

By Ning MingMing  

Translational Stroke Research, Vol. 1, Iss. 4, 2010-12 ,pp. : 268-275

Springer Publishing Company

Access to resources Recommend Favorite

Extension of ischemic therapeutic time window by a free radical scavenger, Edaravone, reperfused with tPA in rat brain

By Zhang Wenri   Sato Keiko   Hayashi Takeshi   Omori Nobuhiko   Nagano Isao   Kato Shinsuke   Horiuchi Seikoh   Abe Koji  

Neurological Research, Vol. 26, Iss. 3, 2004-04 ,pp. : 342-348

Maney Publishing

Access to resources Recommend Favorite

Nitric Oxide Reverses Aspirin Antagonism of t-PA Thrombolysis in a Rabbit Model of Thromboembolic Stroke

By Bednar M.M.   Gross C.E.   Howard D.B.   Russell S.R.   Thomas G.R.  

Experimental Neurology, Vol. 146, Iss. 2, 1997-08 ,pp. : 513-517

Elsevier

Access to resources Recommend Favorite

The possible role of tissue-type plasminogen activator (tPA) and tPA blockers in the pathogenesis and treatment of Alzheimer’s disease

By Melchor Jerry   Pawlak Robert   Chen Zulin   Strickland Sidney  

Journal of Molecular Neuroscience, Vol. 20, Iss. 3, 2003-08 ,pp. : 287-289

Humana Press, Inc

Access to resources Recommend Favorite

Diabetic muscle infarction in a patient with acute embolic stroke

By Huang Eason   Ho Cheng-Feng   Yip Ping-Keung   Lin Yi-Cheng   Tsai Chung-Fen  

Neurological Sciences, Vol. 31, Iss. 3, 2010-06 ,pp. : 345-347

Springer Publishing Company

Access to resources Recommend Favorite